Peter U. Park
No más puestos en curso
Perfil
Dr. Peter U.
Park is Vice President-Biology at Mersana Therapeutics, Inc.
Dr. Park was previously employed as Chief Executive Officer by Habgen, Inc. and Senior Director-Discovery Research by ImmunoGen, Inc.
He received his undergraduate degree from the Massachusetts Institute of Technology and a doctorate degree from the Massachusetts Institute of Technology.
Antiguos cargos conocidos de Peter U. Park.
| Empresas | Cargo | Fin |
|---|---|---|
| IMMUNOGEN, INC. | Corporate Officer/Principal | - |
| Habgen, Inc. | Director Ejecutivo | - |
| MERSANA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formación de Peter U. Park.
| Massachusetts Institute of Technology | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MERSANA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
| Habgen, Inc. |
- Bolsa de valores
- Insiders
- Peter U. Park
